Australia-based dorsaVi, a developer of wearable medical devices, has launched sales of its ViMove platform in the U.S., following 510(k) clearance by the Food and Drug Administration for measuring, recording, and reporting on movement and muscle activity of the lower back and lumbar spine.

ViMove consists of wearable sensors that are placed on the body to measure movement and muscle activity. Patients can be assessed through a series of movements or exercises performed in-clinic, or outside the clinic, at home or at work, where ViMove can monitor their everyday activities, and provide immediate biofeedback to the patient and a concise report for the healthcare practitioner.

The first U.S. installation of ViMove was at Metro Orthopaedics and Sports Therapy in Silver Spring, Md.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access